Understanding Guillain-Barré Syndrome (GBS): A Growing Health Concern in India

 The recent surge in Guillain-Barré Syndrome (GBS) cases in Maharashtra, India, has raised serious concern, with 110 reported cases in Pune as of January 27, 2025, and 13 patients currently on ventilators. In Maharashtra, a 40-year-old patient, who passed away at a private hospital, was brought to the Government Medical College in Solapur for a post-mortem. Preliminary findings indicated GBS as the cause of death, according to Dr. Sanjeev Thakur, Dean of the college. This outbreak highlights the urgency of early diagnosis and treatment in addressing the condition effectively.

GBS is a rare autoimmune disorder in which the immune system attacks the peripheral nerves. GBS, first described globally in 1916 by French neurologists Georges Guillain, Jean Alexandre Barré, and André Strohl, has since been recognized as a rare but potentially life-threatening autoimmune disorder. Key aspects of the condition include:

• Symptoms: Tingling or pins-and-needles sensations, muscle weakness starting in the legs and progressing upward, difficulty with facial movements (chewing, speaking, or swallowing), unsteady walking, severe nerve pain, bladder or bowel dysfunction, and, in severe cases, breathing difficulties and paralysis.
• Treatment: Intravenous immunoglobulin (IVIG) to neutralize the immune attack, plasma exchange (plasmapheresis) to remove harmful antibodies, supportive care like ventilation for respiratory distress, and physical therapy for recovery of strength and mobility. Early intervention significantly reduces complications and improves recovery outcomes.

Globally, GBS remains rare, with an annual incidence of 1-2 cases per 100,000 people. However, the surge in cases in Maharashtra highlights regional vulnerabilities, such as delayed diagnosis, limited access to specialized care, and increased exposure to infections. Internationally, outbreaks have been associated with specific triggers, like the Zika virus and influenza. The situation in India calls for strengthening healthcare infrastructure, promoting vaccination programs to prevent infections, and raising public awareness about early symptoms. By addressing these areas, the burden of GBS can be managed more effectively, ensuring timely care and better outcomes for affected patients.

Read further:

https://www.mayoclinic.org/diseases-conditions/guillain-barre-syndrome/symptoms-causes/syc-20362793

https://www.thehindu.com/news/national/maharashtra/guillain-barr%C3%A9-syndrome-cases-rise-pune/article69149277.ece